Status: current, Defined. Date: 28-Feb 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4671091000168115 | Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) (amlodipine 5 mg + hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 30 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4671101000168113 | Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet, 30, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet, 30, blister pack | Is a | Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet, 30 | true | Inferred relationship | Some | ||
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet, 30, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet, 30, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet, 30, blister pack | has TP | Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) | true | Inferred relationship | Some | ||
| Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet, 30, blister pack | has TPUU | Olmesartan/Amlodipine HCT 20/5/12.5 (MYL) tablet | true | Inferred relationship | Some | 1257828439 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR